A Quick Snapshot of Boston Scientific's Rhythm Management & Neuro Segment

Get the Full StoryBoston Scientific s NYSE: BSX Rhythm Management and Neuro segment accounts for around 30 of the company s value, according to our estimates. The segment includes products such as pacemakers, implantable cardioverter defibrillators ICDs , and electrophysiology products. The segment has...

Share:

More in Business...

RIP office bestie. Here s the upside to a diminishing need to have a friend at work

This 845 kids chair is a tiny version of a design classic

How to manage your anxiety about public speaking

Leaders need to drop their egos. Here s how they can do it

A baby born this year could lose 1 million over their lifetime because of climate change